1. Home
  2. NPCE vs KMDA Comparison

NPCE vs KMDA Comparison

Compare NPCE & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.06

Market Cap

536.6M

Sector

Health Care

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.23

Market Cap

460.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
KMDA
Founded
1997
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.6M
460.3M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
NPCE
KMDA
Price
$16.06
$7.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$18.33
$14.00
AVG Volume (30 Days)
147.3K
53.7K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
3.08%
EPS Growth
29.03
N/A
EPS
N/A
N/A
Revenue
$99,986,000.00
N/A
Revenue This Year
$0.90
$13.94
Revenue Next Year
$24.46
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
25.13
N/A
52 Week Low
$7.56
$6.50
52 Week High
$19.60
$9.35

Technical Indicators

Market Signals
Indicator
NPCE
KMDA
Relative Strength Index (RSI) 47.96 33.08
Support Level $15.40 $6.57
Resistance Level $17.37 $7.41
Average True Range (ATR) 0.80 0.14
MACD -0.10 -0.04
Stochastic Oscillator 27.15 18.65

Price Performance

Historical Comparison
NPCE
KMDA

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: